Press release
Type 1 Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
DelveInsight's, "Type 1 Diabetes Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Type 1 Diabetes pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Explore our latest breakthroughs in Type 1 Diabetes Research. Learn more about our innovative pipeline today! @ Type 1 Diabetes Pipeline Outlook [https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Type 1 Diabetes Pipeline Report
* In October 2024:- Vertex Pharmaceuticals Incorporated- A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus. The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D).
* In October 2024:- Seraxis- This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe recurrent hypoglycemia. The study will also help establish the optimal treatment dose. Although this study is open to patients with all HLA or blood types, immunosuppression to prevent rejection will be required in this first in human study.
* In October 2024:- CellTrans Inc.- This study is a Phase 3 single center, uncontrolled trial in which 1-3 allogeneic pancreatic islet transplants are performed for each study subject. Follow-up evaluations after transplant continue for 52 weeks after the final islet transplantation. Thereafter, subjects may enroll for a 5-year follow-up study and an additional 5 year to 10 year follow-up study to evaluate the function of the islets and to measure and regulate immunosuppressive drug levels and side effects.
* DelveInsight's Type 1 Diabetes pipeline report depicts a robust space with 80+ active players working to develop 100+ pipeline therapies for Type 1 Diabetes treatment.
* The leading Type 1 Diabetes Companies such as Landos Biopharma, Diamyd Medical, Gan&Lee Pharmaceuticals, Zealand Pharma, Kamada, AstraZeneca, Novo Nordisk, Provention Bio Preregistration, Histogen, Vertex Pharmaceuticals, Panbela Therapeutics, Arecor, Bioprojet, Novartis, ImCyse, Adocia, Anelixis Therapeutics, Tolerion, TikoMed, Avotres, REMD Biotherapeutics, Novo Nordisk, and others.
* Promising Type 1 Diabetes Pipeline Therapies such as Euglycemic clamp with BC Combo THDB0207, ORMD-0801 Treatment A, Dapagliflozin, Mylan's insulin glargine, Lantus Registered , and others.
Stay informed about the cutting-edge advancements in Type 1 Diabetes Treatments. Download for updates and be a part of the revolution in cancer care @ Type 1 Diabetes Clinical Trials Assessment [https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Type 1 Diabetes Emerging Drugs Profile
* Teplizumab: Prevention Bio
Teplizumab is an investigational anti-CD3 monoclonal antibody (mAb) being developed for the delay of clinical type 1 diabetes (T1D) in at-risk individuals. In the pivotal TN-10 Study, a single 14-day course of teplizumab delayed insulin-dependent, clinical-stage disease by a median of at least two years in presymptomatic patients with Stage 2 T1D compared to placebo. The observed adverse events were mechanism-based, transient, and predictable, including lymphopenia, transaminase elevations, rash, and cytokine release events.
* Emricasan: Histogen
Emricasan is a potential first-in-class, orally active, pan-caspase inhibitor designed to reduce the activity of enzymes that mediate inflammation and apoptosis. Histogen acquired certain rights to emricasan and other caspase inhibitor compounds as a part of its merger with Conatus Pharmaceuticals Inc. in 2020.
* VX-880: Vertex Pharmaceuticals
VX-880 is an investigational allogeneic stem cell-derived, fully differentiated, insulin-producing islet cell therapy manufactured using proprietary technology. VX-880 is being evaluated for patients who have T1D with impaired hypoglycemic awareness and severe hypoglycemia. VX-880 has the potential to restore the body's ability to regulate glucose levels by restoring pancreatic islet cell function, including glucose-responsive insulin production. VX-880 is delivered by an infusion into the hepatic portal vein and requires chronic immunosuppressive therapy to protect the islet cells from immune rejection.
Learn more about Type 1 Diabetes Drugs opportunities in our groundbreaking Type 1 Diabetes Research and development projects @ Type 1 Diabetes Unmet Needs [https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Type 1 Diabetes pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.
* Oral
* Intravenous
* Subcutaneous
Type 1 Diabetes Products have been categorized under various Molecule types such as
* Small molecule
* Cell Therapy
* Peptides
* Polymer
* Small molecule
* Gene therapy
Discover the latest advancements in Type 1 Diabetes Treatment by visiting our website. Stay informed about how we're transforming the future of Oncology @ Type 1 Diabetes Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Type 1 Diabetes Pipeline Report
* Coverage- Global
* Type 1 Diabetes Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Type 1 Diabetes Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
* Type 1 Diabetes Companies- Landos Biopharma, Diamyd Medical, Gan&Lee Pharmaceuticals, Zealand Pharma, Kamada, AstraZeneca, Novo Nordisk, Provention Bio Preregistration, Histogen, Vertex Pharmaceuticals, Panbela Therapeutics, Arecor, Bioprojet, Novartis, ImCyse, Adocia, Anelixis Therapeutics, Tolerion, TikoMed, Avotres, REMD Biotherapeutics, Novo Nordisk, and others.
* Type 1 Diabetes Pipeline Therapies- Euglycemic clamp with BC Combo THDB0207, ORMD-0801 Treatment A, Dapagliflozin, Mylan's insulin glargine, Lantus Registered , and others.
For a detailed overview of our latest research findings and future plans, read the full details of Type 1 Diabetes Pipeline on our website @ Type 1 Diabetes Drugs and Companies [https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Type 1 Diabetes: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Type 1 Diabetes- DelveInsight's Analytical Perspective
* Late Stage Products (Preregistration)
* Teplizumab: Provention Bio
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* TTP 399: Novo Nordisk
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I/II)
* SBP 101: Takeda Oncology
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Eflornithine oral: Panbela Therapeutics
* Drug profiles in the detailed report.....
* Inactive Products
* Type 1 Diabetes Key Companies
* Type 1 Diabetes Key Products
* Type 1 Diabetes- Unmet Needs
* Type 1 Diabetes- Market Drivers and Barriers
* Type 1 Diabetes- Future Perspectives and Conclusion
* Type 1 Diabetes Analyst Views
* Type 1 Diabetes Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=type-1-diabetes-pipeline-therapeutics-assessment-companies-products-unmet-needs-market-drivers-and-barriers]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Type 1 Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers here
News-ID: 3705329 • Views: …
More Releases from ABNewswire

Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold.
Responding to a Growing Need for Water Damage Restoration
Property owners across Minnesota are increasingly seeking…

Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents.
Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,…

Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces.
In…
![Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices](https://cdn.open-pr.com/9/1/914818326_g.jpg)
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection.
Market Overview: Understanding Tampa Bay Remodeling Investment Trends
Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.…
More Releases for Type
Pressure Pumping Market 2028 By Type, Well Type, Resource Type and Geography
The Insight Partners delivers well-researched industry-wide information on the Pressure Pumping market. It provides information on the market's essential aspects such as top participants, factors driving Pressure Pumping market growth, precise estimation of the Pressure Pumping market size, upcoming trends, changes in consumer behavioral pattern, market's competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the market. Additionally, the report is a compilation of…
Lawn Mowers Market Analysis By Type, End User, Product Type, Fuel Type, Engine P …
Lawn Mowers Market Analysis By Type(Manual, Electric, Petrol, Robotic), By End User(Residential, Commercial), By Product Type(Walk behind Movers, Ride on Movers, Stand on Movers), By Fuel Type(Gas Powered, Propane Powered), By Engine Power(Less than 15 hp, Between 15hp and 30 hp, More than 30 hp), By Blade Type(Cylinder, Standard, Mulching, Lifting), By Drive Type(AWD, FWD, RWD), By Application(Residential, Professional landscaping, Golf Course, Government), By Distribution Channel(Retail Store, Online Website) &…
Automotive Exhaust System Component Market Type, Fuel Type, Treatment Device, Ve …
Automotive Exhaust System Component Market
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Tenneco
Faurecia
Eberspacher
Boysen
Sango
HITER
Yutaka Giken
Calsonic Kansei
Magneti Marelli
Benteler
Sejong Industrial
Katcon
Futaba
Wanxiang
Bosal
Harbin Airui
Dinex
Catar
DSM
Get Sample PDF including full TOC, Tables and Figures @ https://www.ozonemarketreports.com/automotive-and-transportation/global-automotive-exhaust-system-components-market-professional-survey-report-2019/59563
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Exhaust Manifold
Exhaust Pipe
Catalytic Converter
Exhaust Temperature Sensor
Car Muffler
Exhaust…
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Automotive Electric Vacuum Pump Market By Type Diaphragm Type, Swing Piston Type …
Automatic electric vacuum pump is a device that gets the drive from the camshaft in the engine. It can also be run by alternator shaft in some designs. It’s an added benefit to any engine, which has high performance. The primary function of an automatic electric vacuum pump is to drain out the air from brake booster tank hence creating the vacuum, which in turn can be used for application…
Marine Composites Market |By Type |Resin Type|Vessel Type|Fiber Type |Region Ana …
The report includes market segmentation by composites type (metal matrix composite, ceramic matrix composite, polymer matrix composite); polymer matrix composite by fiber type (glass fiber, carbon fiber, others); polymer matrix composite by resin type (polyester, vinyl ester, epoxy, thermoplastic, others); vessel type (power boats, sailboats, cruise ships, others); and region (North America, Europe, APAC, Latin America, MEA).
Download Latest Free PDF Sample Brochure of “Marine Composites Market” With Detailed TOC…